Evidence map›Paper›PMID 30482236›Full record

ArticleJournal of experimental & clinical cancer research : CR2018

Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.

Guanming Lu, Yueyong Li, Yanfei Ma, Jinlan Lu, Yongcheng Chen, Qiulan Jiang, Qiang Qin, Lifeng Zhao, Qianfang Huang, Zhizhai Luo and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06357689 (Studying the Association of Genetic Variations in Long Intergenic Noncoding RNA 00511), which is not on this map. Cited by 166 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed, 4 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06357689 completednot on this mapstarted 2021, after this paper: background citation

Studying the Association of Genetic Variations in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population

TypeobservationalSponsorAin Shams UniversityRan2021 to 2023Enrolled417ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 4 syntheses or guidelines pooled it, 272 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Structure and Functions of HMGB3 Protein.International journal of molecular sciences · 2024
    Review
  20. Article

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Guanming LuDepartment of Mammary and Thyroid Gland Surgery, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Yueyong LiThe First Affiliated Hospital of Jinan university, Huangpu Road, No. 613, Guangzhou, 510630, Guangdong, China.
Yanfei MaDepartment of Mammary and Thyroid Gland Surgery, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Jinlan LuDepartment of Dental, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Yongcheng ChenDepartment of Mammary and Thyroid Gland Surgery, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Qiulan JiangDepartment of Oncology, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Qiang QinDepartment of Mammary and Thyroid Gland Surgery, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Lifeng ZhaoDepartment of Oncology, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Qianfang HuangDepartment of Mammary and Thyroid Gland Surgery, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Zhizhai LuoDepartment of Mammary and Thyroid Gland Surgery, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China.
Shiqing HuangThe First Affiliated Hospital of Jinan university, Huangpu Road, No. 613, Guangzhou, 510630, Guangdong, China. huangshiq97@126.com.
Zhongheng WeiDepartment of Oncology, Youjiang Medical College Affiliated Hospital, Baise, 533000, Guangxi, China. weizhongh_yjmc@aliyun.com.
Youjiang Medical College for Nationalities · CN

Funding

Guangxi Provincial Education Department Funding KY2015YB232, KY2016YB342National Natural Science Foundation of China 81260071
6 · The paper itself

Abstract

backgroundEmerging evidence have illustrated the vital role of long noncoding RNAs (lncRNAs) long intergenic non-protein coding RNA 00511 (LINC00511) on the human cancer progression and tumorigenesis. However, the role of LINC00511 in breast cancer tumourigenesis is still unknown. This research puts emphasis on the function of LINC00511 on the breast cancer tumourigenesis and stemness, and investigates the in-depth mechanism.

methodsThe lncRNA and RNA expression were measured using RT-PCR. Protein levels were measured using western blotting analysis. CCK-8, colony formation assays and transwell assay were performed to evaluate the cell proliferation ability and invasion. Sphere-formation assay was also performed for the stemness. Bioinformatic analysis, chromatin immunoprecipitation (ChIP) and luciferase reporter assays were carried to confirm the molecular binding.

resultsLINC00511 was measured to be highly expressed in the breast cancer specimens and the high-expression was correlated with the poor prognosis. Functionally, the gain and loss-of-functional experiments revealed that LINC00511 promoted the proliferation, sphere-formation ability, stem factors (Oct4, Nanog, SOX2) expression and tumor growth in breast cancer cells. Mechanically, LINC00511 functioned as competing endogenous RNA (ceRNA) for miR-185-3p to positively recover E2F1 protein. Furthermore, transcription factor E2F1 bind with the promoter region of Nanog gene to promote it transcription.

conclusionIn conclusion, our data concludes that LINC00511/miR-185-3p/E2F1/Nanog axis facilitates the breast cancer stemness and tumorigenesis, providing a vital insight for them.

Indexed as

AnimalsBreast NeoplasmsCarcinogenesisCell Line, TumorE2F1 Transcription FactorFemaleHeterograftsHumansMCF-7 CellsMiceMicroRNAsMiddle AgedNanog Homeobox ProteinNeoplastic Stem CellsRNA, Long NoncodingTransfectionE2F1 protein, humanE2F1 Transcription Factorlong non-coding RNA LINC00518, humanMicroRNAsMIRN185 microRNA, humanNanog Homeobox ProteinNANOG protein, humanRNA, Long NoncodingBreast cancer stem cellsE2F1LINC00511miR-185-3pNanog

Identifiers

PMID30482236
PMCPMC6260744
OpenAlexW2902332197

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.